Arcturus Therapeutics Holdings Inc (ARCT)
26.00
-0.33
(-1.25%)
USD |
NASDAQ |
Apr 19, 16:00
26.00
0.00 (0.00%)
After-Hours: 19:05
Arcturus Therapeutics Holdings Revenue (TTM): 157.75M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 157.75M |
| September 30, 2023 | 292.72M |
| June 30, 2023 | 262.71M |
| March 31, 2023 | 280.24M |
| December 31, 2022 | 205.76M |
| September 30, 2022 | 51.50M |
| June 30, 2022 | 40.57M |
| March 31, 2022 | 15.48M |
| December 31, 2021 | 12.36M |
| September 30, 2021 | 8.803M |
| June 30, 2021 | 8.699M |
| March 31, 2021 | 9.02M |
| Date | Value |
|---|---|
| December 31, 2020 | 9.539M |
| September 30, 2020 | 10.27M |
| June 30, 2020 | 11.25M |
| March 31, 2020 | 19.08M |
| December 31, 2019 | 20.79M |
| September 30, 2019 | 25.40M |
| June 30, 2019 | 25.50M |
| March 31, 2019 | 17.74M |
| December 31, 2018 | 15.75M |
| September 30, 2018 | 10.20M |
| June 30, 2018 | 10.07M |
| March 31, 2018 | 11.44M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
8.699M
Minimum
Jun 2021
292.72M
Maximum
Sep 2023
77.23M
Average
20.79M
Median
Dec 2019
Revenue (TTM) Benchmarks
| AIM ImmunoTech Inc | 0.202M |
| Perspective Therapeutics Inc | 0.00 |
| Protalix BioTherapeutics Inc | 65.49M |
| Electromed Inc | 51.69M |
| Armata Pharmaceuticals Inc | -- |